NCT02511353View on ClinicalTrials.gov

Efficacy and Safety of High-dose Ivermectin for Reducing Malaria Transmission: A Dose Finding Study

PHASE2CompletedINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Malaria
Interventions
DRUG

ivermectin

DRUG

placebo

Placebo for ivermectin.

DRUG

dihydroartemisinin-piperaquine

Trial Locations (1)

40100

Jaramogi Oginga Odinga Teaching and Referral Hospital, Kisumu

Sponsors
All Listed Sponsors
collaborator

Kenya Medical Research Institute

OTHER

collaborator

Centers for Disease Control and Prevention

FED

lead

Liverpool School of Tropical Medicine

OTHER